|Measure Name||Diagnostics||Patient Education||Treatment||Self-Management||Monitoring of Disease Status|
|1. Comprehensive Documentation of Indications for PCI†||✓|
|2. Appropriate Indication for Elective PCI‡||✓||✓|
|3. Assessment of Candidacy for Dual-Antiplatelet Therapy†||✓||✓||✓|
|4. Use of Embolic Protection Devices in the Treatment of Saphenous Vein Bypass Graft Disease‡||✓|
|5. Documentation of Preprocedural Glomerular Filtration Rate and Contrast Dose Used During the Procedure‡||✓||✓|
|6. Radiation Dose Documentation‡||✓|
|7. Postprocedural Optimal Medical Therapy Composite†||✓|
|8. Cardiac Rehabilitation Patient Referral†||✓||✓||✓||✓|
|9. Regional or National PCI Registry Participation†||✓|
|10. Annual Operator PCI Volume‡||✓|
|11. Annual Hospital PCI Volume†||✓|
ACC indicates American College of Cardiology; AHA, American Heart Association; AMA-PCPI, American Medical Association–Physician Consortium for Performance Improvement; NCQA, National Committee for Quality Assurance; PCI Percutaneous Coronary Intervention; and SCAI, Society for Cardiovascular Angiography and Interventions.
↵∗ For comprehensive information on these measures, including measure exceptions, please refer to the complete ACC/AHA/AMA-PCPI/NCQA/SCAI performance measurement set through the PCPI Web site (http://www.ama-assn.org/apps/listserv/x-check/qmeasure.cgi?submit=PCPI).
↵† These measures are performance measures.
↵‡ Indicated in shading, these measures have been designated quality metrics and are for use in internal quality-improvement programs only. They are not appropriate for any other use (e.g., pay-for-performance, physician ranking, public reporting programs).